atractylenolide iii has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, R; Liu, L; Lu, L; Pei, T; Wang, F; Wang, M; Wang, Y; Wei, L; Wu, X; Xiao, W; You, H; Zhang, J | 1 |
1 other study(ies) available for atractylenolide iii and Chronic Kidney Diseases
| Article | Year |
|---|---|
Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway.
Topics: Animals; Cholinergic Antagonists; Humans; Lactones; Male; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Sesquiterpenes; TOR Serine-Threonine Kinases | 2019 |